Rare lephants
Screener

Gain Therapeutics, Inc.

GANX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 1, 2026 FORM 8-K
8-K Sep 28, 2026 FORM 8-K
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
4 Jul 17, 2026 OWNERSHIP DOCUMENT
4 Jul 17, 2026 OWNERSHIP DOCUMENT
4 Jul 17, 2026 OWNERSHIP DOCUMENT
4 Jul 17, 2026 OWNERSHIP DOCUMENT
4 Jul 17, 2026 OWNERSHIP DOCUMENT
4 Jul 17, 2026 OWNERSHIP DOCUMENT
8-K Jul 16, 2026 FORM 8-K
8-K Jun 29, 2026 FORM 8-K
8-K Jun 25, 2026 FORM 8-K
8-K May 26, 2026 FORM 8-K
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
4 Mar 26, 2026 OWNERSHIP DOCUMENT
4 Mar 26, 2026 OWNERSHIP DOCUMENT
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
8-K Mar 18, 2026 FORM 8-K
8-K Feb 3, 2026 FORM 8-K
← Newer Page 1 of 10 · 237 filings Older →